NU9056 is a potent and selective KAT5 (Tip60) histone acetyltransferase inhibitor (IC50
are < 2 μM, 60 μM, 36 μM, and >100 μM for KAT5, p300, pCAF and
GCN5, respectively), identified by a high-throughput screening. NU9056
inhibited cellular proliferation in a panel of prostate cancer cell
lines (50% growth inhibition, 8-27 μM) and induced apoptosis via
activation of caspase 3 and caspase 9 in a concentration- and
time-dependent manner. The protein levels of androgen receptor, prostate
specific antigen, p53 and p21 were decreased in response to treatment
with NU9056. Furthermore, pre-treatment with NU9056 inhibited both ATM
phosphorylation and Tip60 stabilization in response to ionizing
radiation. NU9056 is a very useful chemical probe to study Tip60 (KAT5)
histone acetyltransferase function.?
?
How to Use:
In vitro:? NU9056 was used at 24 μM final concentration in vitro and in cellular assays.
In vivo: ?n/a
?
Reference:
1. Coffey K, et al. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer. (2012) PLoS One. 7(10):e45539.?
?
?
Products are for research use only. Not for human use.